Compare ARAY & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARAY | PRT |
|---|---|---|
| Founded | 1990 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.3M | 27.0M |
| IPO Year | 2006 | N/A |
| Metric | ARAY | PRT |
|---|---|---|
| Price | $0.25 | $2.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 497.6K | 22.5K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 13.45% |
| EPS Growth | ★ 87.50 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.58 | N/A |
| P/E Ratio | ★ N/A | $7.78 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $1.82 |
| 52 Week High | $2.10 | $4.01 |
| Indicator | ARAY | PRT |
|---|---|---|
| Relative Strength Index (RSI) | 40.39 | 32.02 |
| Support Level | $0.23 | $2.02 |
| Resistance Level | $0.33 | $2.30 |
| Average True Range (ATR) | 0.02 | 0.05 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 12.33 | 16.00 |
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.